StockWatch
·
Pharmaceuticals
Business Update14 Aug 2026, 12:03 pm

Shukra Pharmaceuticals Lists on NSE

AI Summary

Shukra Pharmaceuticals Limited announced the commencement of trading of its equity shares on the National Stock Exchange of India Limited (NSE) effective August 14, 2026. The shares are admitted to dealings on the Main Board of NSE under the trading symbol SHUKRAPHAR. The ISIN for the equity shares is INE551C01044. The base reference price on NSE was determined by the closing market price on BSE on August 13, 2026. The company's shares will continue to be listed and traded on the BSE Limited (BSE). This dual listing aims to enhance liquidity, expand the investor base, and maximize stakeholder value.

Key Highlights

  • Equity shares of Shukra Pharmaceuticals Limited listed on NSE.
  • Trading commenced on August 14, 2026, under symbol SHUKRAPHAR.
  • Dual listing on BSE and NSE to improve liquidity and investor base.
  • ISIN INE551C01044 confirmed for NSE listing.